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Patients and methods: Polysomnographic (PSG) sleep assessment was done for 30 males includ-
ing 10 healthy subjects and 20 patients with ankylosing spondylitis (AS). Sleep quality, fatigue and
depression were evaluated. Disease speciﬁc variables such as disease activity, functional disability,
global well being and quality of life were recorded.
Results: Ninety percentage of AS patients were classiﬁed as poor sleepers. In comparison to con-
trols, patients with AS experienced prolonged sleep latency, lessened sleep efﬁciency, increased
stages I%, II%, deﬁcient SWS%, higher arousal and periodic leg movement indices in a signiﬁcant
manner. Meanwhile obstructive sleep apnea was not a signiﬁcant ﬁnding. Signiﬁcant correlations
were detected between most of the PSG parameters as well as sleep quality index on one hand
and different disease speciﬁc variables, fatigue, pain, quality of life on the other hand but not with12 Mustafa Mokhtar Street,
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60 O. Abdulaziez, T. Asaaddepressive symptoms. Disease activity, fatigue and quality of life were signiﬁcantly associated with
most of PSG sleep components on the multiple regression analysis model.
Conclusion: AS patients differ negatively in their sleep from normal population both in quantity
and quality. Our ﬁndings suggest that multiple factors are associated with PSG sleep disturbances
including disease activity, fatigue and quality of life. While treating patients, it is important to ques-
tion sleep disorders followed by the performance of PSG in order to optimize the management of
patients with AS.
 2012 Egyptian Society for Joint Diseases and Arthritis. Production and hosting by Elsevier B.V.
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Sleep disturbance is often reported in rheumatic diseases and is
considered to be multifactorial. There are studies documenting
poor sleep quality in rheumatoid arthritis, systemic lupus ery-
thematosus (SLE), osteoarthritis, ﬁbromyalgia and Sjogren’s
syndrome [1–5].
Ankylosing spondylitis (AS) is a systemic and inﬂammatory
disease predominantly affecting the axial skeleton and thoracic
cage. The associated pain and stiffness are the symptoms fre-
quently mentioned by patients, closely followed by the reports
of fatigue and sleep problems that often have a signiﬁcant
impact upon individual’s health related quality of life [6].
Sleep disturbances in AS are poorly documented, there are
only a few studies that have examined sleep quality in AS using
mainly subjective tools [7–9].
The criterion standard for measuring sleep is polysomnog-
raphy (PSG): an objective measurement that assesses actual
physical and psychological processes during sleep periods.
Studies that document sleep disturbance by PSG are infre-
quent in the literature and have mostly concentrated on small
samples of patients [10].
There were only two studies (one of them is Japanese)
[11–12] that had utilized PSG in sleep assessment of patients
with ankylosing spondylitis but their concern was detection
of obstructive sleep apnea and not the detailed sleep architec-
ture of patients. Therefore this study was undertaken to iden-
tify the polysomnographic sleep pattern and its correlation
with disease variables and outcome measures in patients with
ankylosing spondylitis.
2. Patients and methods
Twenty consecutive male patients with AS seen at the outpa-
tient clinic of Rheumatology and Rehabilitation Department
in Ain Shams University Hospitals were included in the study.
Patients fulﬁlled the modiﬁed New York classiﬁcation criteria
for AS [13]. Demographic characteristics and disease duration
were documented. The patients who had ﬁbromyalgia, malig-
nancy and other chronic diseases were excluded from the study.
Ten healthy males have been enrolled in the study as the control
group. A written informed consent was taken from patients and
control subjects before participation in the research work.
The disease activity and functional status of patients were
evaluated by the Bath Ankylosing Spondylitis Disease Activity
Index (BASDAI) [14] and Bath Ankylosing Spondylitis
Functional Index (BASFI) [15], respectively. The Bath
Ankylosing Spondylitis Metrology Index (BASMI) [16], Bath
Ankylosing Spondylitis Global Score (BAS-G) [17] and Visual
Analogue Scale (VAS 0–10 cm) [18] were used for recording ofmetrologic measures, global well-being and pain, respectively.
Fatigue was assessed by the Fatigue Severity Scale (FSS) [19],
while depressive symptoms were detected by Beck Depression
Inventory Scale (BDI) [20] and quality of life was measured
using the Ankylosing Spondylitis Quality of Life Index
(ASQoL) [21]. Sleep disturbances were assessed subjectively
by Pittsburg Sleep Quality Index (PSQI): the scale with a glo-
bal score <5 yielding a differentiating good and poor sleepers
[22] and objectively by polysomnography (PSG): sleep labora-
tory recording was carried out in a sound attenuated, light and
temperature controlled room that has a comfortable bed room
like atmosphere. During this evaluation, each subject was
monitored continuously for 8 h. Electroencephalographic,
electrooculographic, electromyographic, respiratory events
(apnea, hypopnea), oxygen saturation, periodic leg movements
(PLM) recordings were obtained. The sleep recordings were
ampliﬁed using sleep trace 2000 (Sleep trace Corporation, Palo
Alto alife) in the sleep laboratory of Ain Shams University
Psychiatric Institute. All polysomnographs were scored
according to the standard criteria [23]. Sleep parameters as-
sessed for sleep recordings included: sleep latency (SL) which
was deﬁned as latency from lights out to the ﬁrst occurrence
of any stage sleep, sleep efﬁciency (SE) which is total sleep time
as percent of time in bed, percentage of the various sleep stages
which is calculated as the minutes in each stage as the percent
of total sleep time: [(a) nonrapid eye movement [NREM] sleep
which is composed of stages I, II pointing to light sleep, stage
III, stage IV; combined stages III, IV are known as slow wave
sleep (SWS); an indicator of deep sleep, (b) rapid eye move-
ment stage (REM)], rapid eye movement latency (REML)
which is the interval from sleep onset to the ﬁrst REM period,
the number of abnormal breathing events (apnea and hypo-
pnea) per hour of sleep was quantiﬁed as respiratory distur-
bance index (RDI). Periodic leg movement index (PLMI) is
deﬁned as the number of periodic leg movements per hour of
sleep. Arousal index (AI) which is deﬁned as the number of
arousals per hour.
Statistical analysis: Data were collected and analyzed using
SPSS V10 and the following was calculated: Mean and
Standard deviation for continuous variables, Frequency and
percentage for categorical variables. Independent sample
Student’s t test was used for the comparison between two
groups regarding continuous variables. Correlation studies
were done by Pearson correlation coefﬁcient (r) to assess
strength and direction of the linear relationship between two
variables. Multiple linear regression was used to test and esti-
mate the dependence of a quantitative variable based on its
relationship with a set of independent variables. Results were
considered to be signiﬁcant if p< 0.05, highly signiﬁcant if
p< 0.001 and not signiﬁcant if p< 0.05.
Table 1 Demographic and different disease variables of
patients with ankylosing spondylitis.
Age (years) 37.8 ± 5.6
Disease duration (years) 13.1 ± 4.6
BASDAI (0–10) 4.9 ± 1.2
BASFI (0–10) 4.02 ± 1.5
BASMI (0–10) 4.6 ± 1.4
BAS-G (0–10) 5.2 ± 1.3
Pain-VAS (0–10) 4.9 ± 1.4
ASQoL (0–16) 7.5 ± 2.6
BASDAI: Bath Ankylosing Spondylitis Disease activity Index,
BASFI: Bath Ankylosing Spondylitis functional Index, BASMI:
Bath Ankylosing Spondylitis Metrology Index, BAS-G: Bath
Ankylosing Spondylitis Global Score, VAS: visual analogue scale,
ASQoL: Ankylosing spondylitis Quality of Life index, values are in
mean ± SD.
Table 2 Fatigue severity and beck depression inventory scales
in patients and control subjects.
Patients Control p value
FSS 4.8 ± 0.55 2.1 ± 1.2 <0.001
BDI 3.6 ± 3.1 3.0 ± 1.1 0.556
FSS: Fatigue Severity Scale, BDI: Beck Depression Inventory
Scale, signiﬁcant: p< 0.001.
Table 3 Comparison between ankylosing spondylitis patients
and control group regarding different sleep parameters.
Patients Control p value
Stage I% 4.3 ± 0.79 1.9 ± 0.26 <0.001
Stage II% 55.1 ± 1.6 49.6 ± 0.92 <0.001
SWS% 18.3 ± 1.0 23.9 ± 0.32 <0.001
REM% 23.2 ± 1.0 23.9 ± 0.83 0.079
REML (min) 66.5 ± 1.4 65.8 ± 4.1 0.681
AI 11.9 ± 1.8 4.1 ± 1.7 <0.001
PLMI 3.1 ± 0.82 1.5 ± 0.92 <0.001
RDI 0.15 ± 0.24 0.10 ± 0.25 0.634
SL (min) 32.1 ± 8.03 15.4 ± 2.7 <0.001
SE% 75.1 ± 4.3 93.2 ± 2.1 <0.001
PSQI 8.2 ± 1.5 2.4 ± 0.95 <0.001
SWS: slow wave sleep, REM: rapid eye movement, REML: rapid
eye movement latency, AI: arousal index, PLMI: periodic leg
movement index, RDI: respiratory distress index, SL: sleep latency,
SE: sleep efﬁciency, PSQI: Pittsburg Sleep Quality Index, signiﬁ-
cant: p< 0.001.
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The study included 20 male patients with ankylosing spondyli-
tis and 10 healthy age and sex matched control subjects, their
mean age was 36.6 ± 6.1. Table 1 summarizes the demo-
graphic and different disease data of the patients.
Using FSS, the level of fatigue was signiﬁcantly higher in
patients than control subjects while no signiﬁcant difference
could be detected between both groups regarding BDI scale
(Table 2) as 3 patients had mild depressive symptoms and
the remaining 17 patients as well as the control group showed
minimal or absent depressive symptoms.
Polysomnographic sleep assessment revealed that AS
patients when compared to control subjects had experienced
more light sleep as indicated by increased stage I% and stage
II%, less deep sleep which points to decreased SWS%, initial
insomnia due to decreased sleep latency, sleep fragmentation
as denoted by increased arousal index and decreased sleep efﬁ-
ciency. On the other hand no signiﬁcant difference was found
between both groups regarding REML or RDI which are
related to depressive symptoms and obstructive sleep apnea
syndrome, respectively. Poor sleep quality was detected in
18/20 (90%) of patients on the PSQI (Table 3).
Pearson coefﬁcients were used to identify the correlates of
polysomnographic sleep parameters and sleep quality in
patients with ankylosing spondylitis. Initial insomnia, bad
sleep efﬁciency, sleep fragmentation, decreased and increased
percentage of deep and light sleep, respectively as well as poor
sleep quality were signiﬁcantly correlated with higher disease
activity, bad functional status, worse metrology index in-
creased fatigue severity and poor quality of life but this corre-
lation was absent regarding depressive symptoms (Tables 4
and 5) Within polysomnographic ﬁndings; PLMI correlated
in a signiﬁcant negative manner with sleep efﬁciency
r= 0.96, p< 0.001.
Regression models were constructed to identify variables
associated with the most affected polysomnographic sleep
parameters and sleep quality. According to multiple regression
analysis (Table 6), it has been found out that BASDAI and
FSS were associated with light and deep sleep (stage I% and
SWS%, respectively). Regression models with sleep fragmenta-
tion (arousal index) and initial insomnia (sleep latency) as
dependent variables revealed three contributions fromBASDAI, ASQoL and FSS. The independent factors: ASQoL
and FSS were signiﬁcant indicators for lessened sleep efﬁ-
ciency. Finally the only signiﬁcant factor associated with sleep
quality was FSS (Table 7).
4. Discussion
Sleep disturbances are increased in AS, but much is not known
in a quantitative way about these problems [24]. This is the ﬁrst
study assessing polysomnograhic sleep components in a de-
tailed manner and investigating their correlations with disease
speciﬁc variables and outcome measures especially from the
Egyptian subcontinent.
The current study had demonstrated a higher percentage of
poor sleep quality in 90% of AS patients compared to a previ-
ous study which showed that 54.8% of patients were classiﬁed
as poor sleepers using PSQI [25], the difference may be due to
that they have included increased number of patients in their
work. On the other hand, earlier reports had detected sleep
disturbances in 80.5% and 96% of SLE and ﬁbromyalgia
patients, respectively [4,26] in parallel to our results.
Insomnia is characterized by difﬁculty in initiating or main-
taining sleep [27]. AS patients in our study and ﬁbromyalgia
patients in a former study [28] had experienced initial insomnia
as indicated by prolonged sleep latency in comparison to
control subjects. While polysomnographic sleep assessment
of patients with Behcet disease resulted in the absence of initial
insomnia [29].
Increased light sleep was detected in our patients as marked
by the signiﬁcant higher percentages of stages I and II versus
Table 4 The correlation between polysomnographic sleep parameters and disease related variables in ankylosing spondylitis patients.
Stage II% SWS% REML RDI AI PLMI SL SE%
Age r 0.92* 0.97* 0.19 0.12 0.96* 0.95* 0.96* 0.98*
Disease duration r 0.72* 0.93* 0.32 0.16 0.88* 0.94* 0.89* 0.92*
BASDAI r 0.71* 0.87* 0.29 0.11 0.81* 0.88* 0.86* 0.86*
BASFI r 0.73* 0.94* 0.34 0.22 0.88* 0.96* 0.90* 0.96*
BASMI r 0.74* 0.93* 0.29 0.18 0.86* 0.95* 0.89* 0.91*
BAS-G r 0.84* 0.97* 0.26 0.15 0.92* 0.97* 0.93* 0.97*
Pain-VAS r 0.72* 0.95* 0.36 0.19 0.86* 0.95* 0.91* 0.90*
ASQoL r 0.75* 0.94* 0.28 0.18 0.87* 0.97* 0.90* 0.91*
FSS r 0.79* 0.97* 0.32 0.19 0.91* 0.98* 0.93 0.95*
BDI r 0.37 0.36 0.37 0.06 0.35 0.29 0.34 0.32
SWS: slow wave sleep, REML: rapid eye movement latency, RDI: respiratory distress index, AI: arousal index, PLMI: periodic leg movement
index, SL: sleep latency, SE: sleep efﬁciency, BASDAI: Bath Ankylosing Spondylitis Disease activity Index, BASFI: Bath Ankylosing Spon-
dylitis functional Index, BASMI: Bath Ankylosing Spondylitis Metrology Index, BAS-G: Bath Ankylosing Spondylitis Global Score, VAS:
visual analogue scale, ASQoL: Ankylosing spondylitis Quality of Life index, FSS: Fatigue Severity Scale, BDI: Beck Depression Inventory
Scale.
* Signiﬁcant (p< 0.001) otherwise not signiﬁcant.
Table 5 Correlation between sleep quality index and different
disease parameters in patients with ankylosing spondylitis.
PSQI
r p
Age 0.99 <0.001
Disease duration 0.90 <0.001
BASDAI 0.86 <0.001
BASFI 0.90 <0.001
BASMI 0.91 <0.001
BAS-G 0.96 <0.001
Pain-VAS 0.90 <0.001
ASQoL 0.91 <0.001
FSS 0.94 <0.001
BDI 0.31 0.173
PSQI: Pittsburg Sleep Quality Index, BASDAI: Bath Ankylosing
Spondylitis Disease activity Index, BASFI: Bath Ankylosing
Spondylitis functional Index, BASMI: Bath Ankylosing Spondylitis
Metrology Index, BAS-G: Bath Ankylosing Spondylitis Global
Score, VAS: visual analogue scale, ASQoL: Ankylosing spondylitis
Quality of Life index, FSS: Fatigue Severity Scale, BDI: Beck
Depression Inventory Scale, signiﬁcant: p< 0.001.
Table 7 Multivariate regression analysis with sleep quality as
dependent variable in patients with ankylosing spondylitis.
PSQI
b p
BASDAI 0.308 0.142
BASFI 0.626 0.122
ASQoL 0.880 0.063
FSS 2.72 <0.001
R2 0.93
PSQI: Pittsburg Sleep Quality Index, BASDAI: Bath Ankylosing
Spondylitis Disease activity Index, BASFI: Bath Ankylosing
Spondylitis functional Index, ASQoL: Ankylosing spondylitis
Quality of Life index, FSS: Fatigue Severity Scale, signiﬁcant:
p< 0.001.
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laboratory sleep research on patients with AS that had re-
ported nearly the same mean of stage II% [11]. Two nights
of polysomnography in 14 patients with osteoarthritis showedTable 6 Regression models predicting abnormalities in polysomno
Stage I% SWS% Arou
b p b p b
BASDAI 0.345 0.011 0.402 0.017 0.5
BASFI 0.225 0.336 0.440 0.147 0.3
ASQOL 0.493 0.078 0.643 0.071 1.3
FSS 2.01 <0.001 2.41 <0.001 3.0
R2 0.97 0.96 0.9
SWS: slow wave sleep, BASDAI: Bath Ankylosing Spondylitis Disease a
ASQoL: Ankylosing spondylitis Quality of Life index, FSS: Fatigue Sevea higher percentage of stage I% compared to those seen in 16
matched healthy controls [30].
Lessened sleep efﬁciency was a recorded polysomnographic
ﬁnding among patients with Behcet disease [29] which is in par-
allel with our results as the mean value of sleep efﬁciency of pa-
tients was 75.1 ± 4.3 that is similar to a single study on
patients with ankylosing spondylitis [11].
Sleep fragmentation as reﬂected by the signiﬁcant increase
in arousal and periodic leg movement indices was anothergraphic sleep parameters of ankylosing spondylitis patients.
sal index Sleep latency Sleep eﬃciency %
p b p b p
34 0.046 0.731 <0.001 0.167 0.367
24 0.503 0.253 0.395 0.609 0.097
2 0.027 1.26 0.002 1.146 0.011
4 0.001 3.127 <0.001 2.83 <0.001
0 0.96 0.94
ctivity Index, BASFI: Bath Ankylosing Spondylitis functional Index,
rity Scale, signiﬁcant: p< 0.001, signiﬁcant: p< 0.05.
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Hart et al. [31] gave a good description of the patient with
AS who is found to exercise during the night to be able to rise
in the morning. In addition, sleep physiology in rheumatoid
arthritis was mentioned in several papers as fragmented; awak-
ening, arousals and movements tend to be prevalent in their
patients [1,32–33]. Another considered point is that PLMI
was correlated with sleep efﬁciency in systemic sclerosis pa-
tients [34] and our AS patients suggesting that the higher rate
of periodic leg movement, the lower the sleep efﬁciency.
In accordance with our work, two former studies had re-
corded reduced SWS% among systemic lupus erythematosus
and ﬁbromyalgia patients which means that those patients
have shortage in deep sleep [35–36]. Adding to this the signif-
icant relation between reduced SWS% and the sense of fatigue
[37].
No signiﬁcant difference could be detected between AS
patients and control subjects regarding REM latency. This is
the same ﬁnding that had been obtained by two studies inves-
tigating sleep disturbances in rheumatoid arthritis and Behcet
diseases [29,38]. But the signiﬁcant relation between reduced
REM latency and depression could not be proved in this study
on the contrary to a previous report [37].
Several papers have documented the presence of obstructive
sleep apnea syndrome among patients with AS [11,39] which
was not matching with our results as the RDI was not signif-
icantly different between patients and controls. This may be
due to the smaller number of the studied sample in this work.
Sleep in our AS patients was characterized by low efﬁ-
ciency, deﬁcits in slow wave sleep and frequent awakening.
This pattern is consistent with the pattern of unrestorative
sleep described in patients with ﬁbromyalgia [40].
A recent study on patients with different rheumatic diseases
[41] had agreed with our work on AS patients regarding the
relationship between poor sleep quality using PSQI on one
hand and higher pain levels, greater fatigue, poorer global
function, quality of life measures and disease activity indices
on the other hand.
We have detected a strong correlation between most of the
polysomnographic sleep components and different disease vari-
ables including BASDAI and BASFI. It is not surprising that
patients with increased disease activity measured with BASDAI
would have more sleep problems indicating that disease activity
plays an important role in sleep disturbances [24]. Similarly a
signiﬁcant relation between morning stiffness, pain, Ritchie
articular index scores and polysomnographic parameters have
been detected in patients with rheumatoid arthritis pointing
to the important aspects of sleep interaction in rheumatoid
arthritis [42–43]. The severity score was negatively correlated
with sleep efﬁciency among patients with Behcet disease [29].
Among patients with ankylosing spondylitis, sleep distur-
bances were associated with fatigue which is considered one
of the cardinal complaints in AS [25,44]. A ﬁnding which sup-
ports the strong correlation between fatigue level using FSS
and the abnormalities in important sleep variables of our AS
patients such as increased light sleep, poor efﬁciency, pro-
longed latency, sleep fragmentation and deﬁcient deep sleep.
It has been proposed that sleep disturbance may have an
important effect on fatigue and the efforts to improve patient’s
sleep may be a way to decrease fatigue [8].
Pain is recognized as the major health issue for patients
with AS [45]. Sleep disturbance is often reported by ASpatients, with awakenings produced by inﬂammatory pain
[25]. In a study involving 11 subjects with AS, pain correlated
signiﬁcantly with difﬁculty initiating sleep, increased stage one
and movement time [46]. Pain had predicted subsequent sleep
problems among patients with rheumatoid arthritis [47]. Sev-
eral opinions are ongoing with our results.
On the contrary to our ﬁndings, sleep disturbances have
been related to depression in patients with spondyloarthropa-
thies and ﬁbromyalgia syndrome [48–49] .This difference may
be attributed to the various scales used for the assessment of
depression and sleep troubles.
One of the most important quality of life concerns in AS is
poor sleep [7]. This has been proved in our study through the
detection of signiﬁcant correlations between different poly-
somnographic sleep parameters as well as poor sleep quality
and health related quality of life measured by ASQoL index.
Using multiple regression analysis model, the current study
had revealed that disease activity and fatigue were signiﬁcantly
associated with increased light sleep, lessened deep sleep, more
fragmentation, and initial insomnia, while quality of life was a
signiﬁcant predictor for three important polysomnographic
parameters including increased arousal index, delayed sleep
latency and decreased efﬁciency. Meanwhile BASFI was not
a signiﬁcant contributor to any of those sleep constituents.
Interestingly, FSS was found to be the only signiﬁcant associ-
ate with poor sleep quality on PSQI. This may indicate that
polysomnographic sleep assessment represents an accurate
and explanatory tool for sleep disturbances [50].
In a recent study analyzing the priorities of improvement in
the dimensions of health across inﬂammatory rheumatic
diseases, patients with AS reported a signiﬁcant and more
frequent improvement in sleep problems [51].
In conclusion, patients with AS differ negatively in their
sleep from normal population both in quantity and quality.
Our ﬁndings suggest that multiple factors are associated with
polysomnographic sleep disturbances including disease activ-
ity, fatigue and quality of life. We suggest that patients may
beneﬁt by incorporating an evaluation of sleep health into
their standard clinical assessment. Obviously our sample size
is small, however this can provide a documented expense re-
lated to laboratory research which may form a base for future
studies on larger scales of AS patients. Pharmacological and
nonpharmacological interventions are needed to improve sleep
and optimize the management of patients with AS.5. Conﬂict of interest
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